📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours. (2022)

First Author: Mowday AM

Attributed to: SBRC NOTTINGHAM: Sustainable Routes to Platform Chemicals funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41417-021-00296-7

PubMed Identifier: 33558701

Publication URI: http://europepmc.org/abstract/MED/33558701

Type: Journal Article/Review

Volume: 29

Parent Publication: Cancer gene therapy

Issue: 2

ISSN: 0929-1903